| RMD |
Report |
Revenue |
IN-LINE |
pred ~$1.474B vs. cons $1.460B |
MEDIUM |
| RMD |
Report |
Operating diluted EPS |
BEAT |
pred ~$2.930 vs. cons $2.891 |
MEDIUM |
| RMD |
Report |
Global devices sales |
BEAT |
pred ~$755M vs. cons $744.5M |
MEDIUM |
| RMD |
Guide |
FY27 revenue framework |
BETTER |
guide ~$6.14B vs. cons $5.942B |
LOW |
| RMD |
Guide |
FY27 gross-margin framework |
BETTER |
guide ~63–64% vs. cons 62.6% |
LOW |
| RMD |
Guide |
FY27 buyback cadence |
UNCHANGED |
guide >$800M vs. cons UNVERIFIED |
LOW |
| RMD |
Return |
Day-1 residual (stock − beta × S&P 500) |
+4.0% |
— |
LOW |
| RMD |
Return |
5-day cumulative residual |
+5.0% (FOLLOW-THROUGH) |
FOLLOW-THROUGH — FY27 estimate support and buyback confirmation |
LOW |